Chaoyi Yuan
Overview
Explore the profile of Chaoyi Yuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pan Y, Yuan C, Zeng C, Sun C, Xia L, Wang G, et al.
Mol Cancer
. 2025 Feb;
24(1):52.
PMID: 39994696
Cancer stem cells (CSCs) are central to tumor progression, metastasis, immune evasion, and therapeutic resistance. Characterized by remarkable self-renewal and adaptability, CSCs can transition dynamically between stem-like and differentiated states...
2.
Yuan C, He C, Zuo L, Liu B, Qi H
Sci Rep
. 2025 Jan;
15(1):3052.
PMID: 39856373
Retinal vein occlusion (RVO) is the leading cause of vision loss due to an obstruction in the retinal venous system. While RVO is often linked to thrombotic tendencies and coagulation...
3.
Mo J, Su C, Li P, Yang Z, Tao R, Liu Q, et al.
Autophagy
. 2024 Dec;
:1-20.
PMID: 39689859
RETREG1/FAM134B is known for its role as a reticulophagy receptor. Our previous study established that RETREG1 is upregulated in hepatocellular carcinoma (HCC) and contributes to disease progression by activating the...
4.
Li P, Zhou M, Gan X, Yuan C, Li G, Jin G, et al.
Discov Oncol
. 2024 Sep;
15(1):479.
PMID: 39331207
Purpose: The characteristic of RENT3B in cancer remains ambiguous. We aimed to study the relationship between RENT3B and immune infiltration in liver hepatocellular carcinoma (LIHC) and lung squamous cell carcinoma...
5.
Ning D, Jin J, Fang Y, Du P, Yuan C, Chen J, et al.
Clin Transl Med
. 2024 Feb;
14(2):e1529.
PMID: 38303609
Objective: Our study was to elucidate the role of RNA helicase DEAD-Box Helicase 17 (DDX17) in NAFLD and to explore its underlying mechanisms. Methods: We created hepatocyte-specific Ddx17-deficient mice aim...
6.
Yuan C, Jin G, Li P, Wang W, Ge C, Pan Y, et al.
Kidney Int
. 2023 Jul;
104(4):769-786.
PMID: 37482091
Tubulointerstitial fibrosis is considered the final convergent pathway of progressive chronic kidney diseases (CKD) regardless of etiology. However, mechanisms underlying kidney injury-induced fibrosis largely remain unknown. Recent studies have indicated...
7.
Pan Y, Han M, Zhang X, He Y, Yuan C, Xiong Y, et al.
Cell Oncol (Dordr)
. 2022 Jan;
45(1):163-178.
PMID: 35089546
Purpose: Hepatocellular carcinoma (HCC) is one of the most common cancers in the world with a high mortality rate. Receptor tyrosine kinases play important roles in the occurrence and development...
8.
Song J, Liu Y, Liu F, Zhang L, Li G, Yuan C, et al.
Theranostics
. 2021 Jan;
11(3):996-1015.
PMID: 33391517
Resistance to anoikis, cell death due to matrix detachment, is acquired during tumor progression. The 14-3-3σ protein is implicated in the development of chemo- and radiation resistance, indicating a poor...
9.
Liu F, Qin L, Liao Z, Song J, Yuan C, Liu Y, et al.
Exp Hematol Oncol
. 2020 Jun;
9:10.
PMID: 32509418
Background: Immune cell infiltration in the tumor microenvironment (TME) affects tumor initiation, patients' prognosis and immunotherapy strategies. However, their roles and interactions with genomics and molecular processes in hepatocellular carcinoma...
10.
Liu F, Liao Z, Song J, Yuan C, Liu Y, Zhang H, et al.
J Cell Biochem
. 2019 Nov;
121(3):2582-2594.
PMID: 31692036
Although methods in diagnosis and therapy of hepatocellular carcinoma (HCC) have made significant progress in decades, the overall survival (OS) of HCC remains dissatisfactory, so it is particularly important to...